JSM 2004 - Toronto

JSM Activity #368

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
368 Applied Session Wed, 8/11/04, 2:00 PM - 3:50 PM TCC-714 B
Statistical Challenges and Issues in the Analysis of Radiographic Data from Rheumatoid Arthritis Clinical Trials - Topic Contributed - Papers
Biopharmaceutical Section
Organizer(s): Guowen (Gordon) Sun, Amgen, Inc.
Chair(s): Peter A. Lachenbruch, U.S. Food and Drug Administration
     2:05 PM   An Introduction to the Analysis and Interpretation of Radiographic Data from Rheumatoid Arthritis Clinical Trials — James Whitmore, Amgen, Inc.; Guowen (Gordon) Sun, Amgen, Inc.; Wayne Tsuji, Amgen, Inc.
     2:25 PM   Handling Missing Radiographic Data in Rheumatoid Arthritis Clinical Trials — Kimberly L. DeWoody, Centocor, Inc.
     2:45 PM   Comparison of Methods for Missing Data Imputations in the Analysis of Radiographic Data from a Large Phase III Trial — Guowen (Gordon) Sun, Amgen, Inc.; Pilita Canete, Amgen, Inc.; James Whitmore, Amgen, Inc.; Gary Aras, Amgen, Inc.; Nick Fotheringham, Amgen, Inc.
     3:05 PM   Issues Scoring Radiographs and the Use of Multiple Readers — Ronald D. Pedersen, Wyeth Pharmaceuticals
     3:25 PM   Regulatory Guidelines and FDA's Perspective on the Collection and Analysis of the Radiographic Data in Rheumatoid Arthritis Clinical Trials — Boguang A. Zhen, U.S. Food and Drug Administration
     3:45 PM   Floor Discussion
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004